prevention of corneal allograft rejection or graft failure 52 weeks [clinicaltrials_resource:d6a43f90528e807857cd8af2b1b46d12]
LX201 implant contained 30% cyclosporine A by weight and 0.50 inch in length
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
prevention of corneal allograft rejection or graft failure 52 weeks [clinicaltrials_resource:d6a43f90528e807857cd8af2b1b46d12]
LX201 implant contained 30% cyclosporine A by weight and 0.50 inch in length
Bio2RDF identifier
d6a43f90528e807857cd8af2b1b46d12
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d6a43f90528e807857cd8af2b1b46d12
measure [clinicaltrials_vocabulary:measure]
prevention of corneal allograft rejection or graft failure
time frame [clinicaltrials_vocabulary:time-frame]
description
LX201 implant contained 30% cyclosporine A by weight and 0.50 inch in length
identifier
clinicaltrials_resource:d6a43f90528e807857cd8af2b1b46d12
title
prevention of corneal allograft rejection or graft failure 52 weeks
@en
type
label
prevention of corneal allograf ...... 43f90528e807857cd8af2b1b46d12]
@en